2025-11-25 - CoA - Edwards Lifesciences v. Meril - UPC_CoA_27/2025
- Aktenzeichen:
- UPC_CoA_27/2025
- Datum:
- Spruchkörper:
- Court of Appeal - Luxembourg (LU)
- Art:
- Final Decision
- Parteien:
- Edwards Lifesciences Corporation v. Meril Gmbh, Meril Life Sciences Pvt Ltd.
Kernaussage: Landmark CoA decision establishing the UPC's inventive step framework (objective problem, realistic starting point, would-arrive test), confirming that Art.
2025-11-25 - CoA - Edwards Lifesciences
v.
Meril - UPC_CoA_27/2025
landmark
Landmark CoA decision establishing the UPC's inventive step framework (objective problem, realistic starting point, would-arrive test), confirming that Art. 63(1) UPCA creates a civil law claim to injunctive relief (not discretionary), and allowing patient interests to limit injunctions proportionally. Patent maintained under Auxiliary Request II. Infringement by Meril Myval Octacor upheld. Injunction modified for XL heart valves (physician notification replaces Edwards portal). Interim cost awards capped at 50% of recoverable ceiling.
Nichtigkeitsgründe
Art. 138 EPCInventive Step
Patent survived (this ground)Art. 56 EPC · Art. 138(1)(a) EPC
“Patent maintained under Aux Request II. Court set out comprehensive inventive step framework.”
Added Matter
Patent invalid (this ground)Art. 123(2) EPC · Art. 138(1)(c) EPC
“Main Request and Aux Request I revoked for added matter.”